Market research
SBM.V Sirona Biochem Corp
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.73
- Dividend yield
- Not available
- Beta
- -0.24
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA82967M1005
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.73
- Dividend yield
- Not available
- Beta
- -0.24
About
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SBM.V discussion.
5 years, 5 months ago
Sirona Biochem Corp is currently in a long term downtrend where the price is trading 25.5% below its 200 day moving average.
From a valuation standpoint, the stock is 27.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 740.0.
Sirona Biochem Corp's total revenue rose by inf% to $18K since the same quarter in the previous year.
Its net income has increased by 64.6% to $-676K since the same quarter in the previous year.
Finally, its free cash flow fell by 23.9% to $-745K since the same quarter in the previous year.
Based on the above factors, Sirona Biochem Corp gets an overall score of 3/5.